[HTML][HTML] Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients
We evaluated the age-specific mortality of unselected adult outpatients infected with SARS-
CoV-2 treated early in a dedicated COVID-19 day hospital and we assessed whether the …
CoV-2 treated early in a dedicated COVID-19 day hospital and we assessed whether the …
Update alert 3: hydroxychloroquine or chloroquine for the treatment or prophylaxis of COVID-19
This report, the third update of a previously published living systematic review (1), focuses
on treatment (not prophylaxis) of coronavirus disease 2019 (COVID-19) with …
on treatment (not prophylaxis) of coronavirus disease 2019 (COVID-19) with …
Hydroxychloroquine and mortality in COVID-19 patients: a systematic review and a meta-analysis of observational studies and randomized controlled trials
Background: Hydroxychloroquine (HCQ) was proposed as potential treatment for COVID-19,
but its association with mortality is unclear. We reviewed published literature for evidence of …
but its association with mortality is unclear. We reviewed published literature for evidence of …
Randomized controlled trials of early ambulatory hydroxychloroquine in the prevention of COVID-19 infection, hospitalization, and death: meta-analysis
Objective To determine if hydroxychloroquine (HCQ) reduces the incidence of new illness,
hospitalization or death among outpatients at risk for or infected with SARS-CoV-2 (COVID …
hospitalization or death among outpatients at risk for or infected with SARS-CoV-2 (COVID …
Outcomes of 2111 COVID-19 hospitalized patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France, 2020: a monocentric …
Objectives We evaluated the 6-week mortality of SARS-CoV-2 hospitalized patients treated
using a standardized protocol in 2020 in Marseille, France. Methods A retrospective …
using a standardized protocol in 2020 in Marseille, France. Methods A retrospective …
COVID-19 outbreak in Italy: report on the first 124 consecutive patients treated at home
L Cavanna, G Cremona, C Citterio… - The Tohoku Journal of …, 2021 - jstage.jst.go.jp
North Italy emerged as an epicenter of COVID-19 in the Western world. The majority of
studies of patients with COVID-19 have focused on hospitalized patients, and data on early …
studies of patients with COVID-19 have focused on hospitalized patients, and data on early …
[PDF][PDF] Hydroxychloroquine in Early Treatment of High-Risk COVID-19 Outpatients: Efficacy and Safety Evidence
HA Risch - Sixth version. Available online: https://earlycovidcare …, 2021 - canucklaw.ca
Numerous studies by now have examined use of hydroxychloroquine (HCQ) with respect to
a range of outcomes in COVID-19 disease, to the point that indiscriminate or “cherry-picked” …
a range of outcomes in COVID-19 disease, to the point that indiscriminate or “cherry-picked” …
Low dose hydroxychloroquine is associated with lower mortality in COVID-19: a meta-analysis of 26 studies and 44,521 patients
Background Hydroxychloroquine (HCQ) was proposed as potential treatment for COVID-19,
but its association with mortality is not well characterized. We conducted two meta-analyses …
but its association with mortality is not well characterized. We conducted two meta-analyses …
Correct Use of HCQ Did Not Cause Extra Fatalities in COVID-19: Infection
A recent study has claimed that nearly 17,000 people in the US and five other countries died
prematurely during the early stages of the COVID-19 pandemic due to the compassionate …
prematurely during the early stages of the COVID-19 pandemic due to the compassionate …
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid‐19 Hospitalized Patients through Hierarchical Clustering
The efficacy of hydroxychloroquine (HCQ) in treating SARS‐CoV‐2 infection is harshly
debated, with observational and experimental studies reporting contrasting results. To clarify …
debated, with observational and experimental studies reporting contrasting results. To clarify …